KLAC vs RCKTW
KLA Corporation (KLAC) versus Rocket Pharmaceuticals, Inc. Warrant (RCKTW) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US. It is led by Richard P. Wallace.
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is a biotechnology company listed on US.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
RCKTW does not have a complete income-statement cache yet.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. RCKTW currently screens at market cap $0.
Not investment advice. Open the KLAC and RCKTW stock pages for the full models.
Not investment advice.